Showing results (1-10 of 231) with videos related to
Sort By:
Pageof 24
Clinical Rheumatology|September 1, 1991
Liver scan abnormalities in polymyalgia rheumatica/giant cell arteritisV Kyle, E P Wraight, B L HazlemanAnnals of the Rheumatic Diseases|April 1, 1983
Yttrium-90 therapy and 99MTc pertechnetate knee uptake measurements in the management of rheumatoid arthritisV Kyle, B L Hazleman, E P WraightAnnals of the Rheumatic Diseases|March 1, 1990
Rarity of synovitis in polymyalgia rheumaticaV Kyle, J Tudor, E P Wraight, et al.Annals of the Rheumatic Diseases|August 1, 1989
Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effectsV Kyle, B L HazlemanAnnals of the Rheumatic Diseases|August 1, 1989
Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two monthsV Kyle, B L HazlemanAnnals of the Rheumatic Diseases|December 1, 1993
The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatmentV Kyle, B L HazlemanAnnals of the Rheumatic Diseases|August 1, 1989
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow upV Kyle, T E Cawston, B L HazlemanThe Journal of Rheumatology|September 1, 1992
Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenonM V Kyle, G Belcher, B L HazlemanClinical Rheumatology|September 1, 1984
Polymyalgia rheumatica/giant cell arteritis in husband and wifeM V Kyle, B L Hazleman, R H KingAnnals of the Rheumatic Diseases|August 1, 1984
Abnormal radionuclide liver scans in giant cell arteritisJ Jones, M V Kyle, B L Hazleman, et al.Pageof 24